Gilead Sciences Poland Sp. z o.o. (Poland)

Gilead Sciences Poland Sp. z o.o. is the Polish affiliate of Gilead Sciences, a global biopharmaceutical company focused on innovative therapies in virology, oncology and inflammatory diseases. The entity is based in Warsaw and supports the commercialization, medical affairs, regulatory, market access and pharmacovigilance activities related to Gilead's portfolio in Poland and, for selected functions, in the Baltic markets. Its business covers prescription medicines for the treatment and prevention of HIV infection, chronic viral hepatitis, including hepatitis B and C, COVID-19 and other serious viral diseases, as well as oncology and hematology products and treatments for inflammatory and fibrotic conditions that Gilead is bringing to market. Gilead Sciences Poland works closely with hospitals, specialist clinics, scientific societies and patient organizations, providing medical education and supporting clinical research and real-world evidence projects in its core therapeutic areas. The company leverages Gilead's global R&D pipeline and manufacturing network to secure supply of innovative medicines to Polish patients and to contribute to national therapeutic programs in infectious diseases and cancer. Strategic priorities for the Polish affiliate include expanding patient access to breakthrough therapies, partnering with the healthcare system to improve treatment standards and outcomes in virology and oncology, and supporting policy and system solutions that strengthen long-term public health resilience.